Back

Association between Alzheimer's disease and COVID-19: A bidirectional Mendelian randomization

Liu, D.; Zhang, X.; Cao, W.; Zhang, J.; Song, M.; Xing, W.; Wang, W.; Meng, Q.; Wang, Y.

2020-07-30 genetic and genomic medicine
10.1101/2020.07.27.20163212 medRxiv
Show abstract

BackgroundIn observational studies, Alzheimers disease (AD) has been associated with an increased risk of Coronavirus disease 2019 (COVID-19), and the prognosis of COVID-19 can affect nervous systems. However, the causality between these conditions remains to be determined. MethodsThis study sought to investigate the bidirectional causal relations of AD with COVID-19 using two-sample Mendelian randomization (MR) analysis. ResultsWe found that genetically predicted AD was significantly associated with higher risk of severe COVID-19 (odds ratio [OR], 3.329; 95% confidence interval [CI], 1.139-9.725; P=0.028). Its interesting that genetically predicted severe COVID-19 was also significantly associated with higher risk of AD (OR, 1.004; 95% CI, 1.001-1.007; P=0.018). In addition, the two strong genetic variants associated with severe COVID-19 was associated with higher AD risk (OR, 1.018; 95% CI, 1.003-1.034; P=0.018). There is no evidence to support that genetically predicted AD was significantly associated with COVID-19 susceptibility, and vice versa. No obvious pleiotropy bias and heterogeneity were observed. ConclusionOverall, AD may causally affect severe COVID-19, and vice versa, performing bidirectional regulation through independent biological pathways.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.